The function of TIM-3 as a key regulator of T cells is well recognized [35,36], with its over-expression implicated in glioblastoma progression [32,37,38,39], and our current data demonstrate that TIM-3 expression correlates with poor glioblastoma survival. The gene discussed is HAVCR2; the disease is glioblastoma.